Invus Global Management, LLC 13D and 13G filings for Lexicon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-08 9:42 pm Purchase | 2026-04-30 | 13D | LEXICON PHARMACEUTICALS INC CO LXRX | Invus Global Management, LLC | 175,156,062 39.400% | 20,421,735 (+13.20%) | Filing |
| 2026-02-02 9:54 pm Purchase | 2026-01-29 | 13D | LEXICON PHARMACEUTICALS INC CO LXRX | Invus Global Management, LLC | 154,734,327 36.200% | 154,734,327 (New Position) | Filing |